2B4-27330-11345
3 vaccinations
3 coded responses
26 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 852 / AZ
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
- 2021-01-11
-
2021-01-15
Dose 2 — Pfizer-BioNTech
- 2021-01-20
- 2021-01-22
- 2021-01-29
- 2021-02-06
- 2021-02-12
- 2021-02-19
- 2021-02-28
- 2021-04-16
- 2021-07-17
-
2021-12-08
Dose 3 — Pfizer-BioNTech
-
2021-12-11
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: Swollen lymph nodes, armpit, collarbone and neckMedDRA releases: 2024-11 · check-in free text available
- 2021-12-12
- 2022-01-07
-
2022-01-12
Survey response — day 35, dose 3MedDRA: Fatigue, Headache, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: I developed runny nose, fatigue and headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-01-22
-
2022-03-09
Survey response — 3 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-03-09
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-10
- 2022-06-08
- 2022-12-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-12-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-09 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph nodes, armpit, collarbone and neck
Release 10 — day 35, dose 3
Symptoms: I developed runny nose, fatigue and headache
Release 11 — 3 months, dose 3
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release